Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-104715
Filing Date
2026-03-12
Accepted
2026-03-12 20:15:07
Documents
1
Period of Report
2026-03-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6739
  Complete submission text file 0001193125-26-104715.txt   8282
Mailing Address 104 5TH AVENUE 19TH FLOOR NEW YORK NY 10011
Business Address
Mathers Edward T (Reporting) CIK: 0001328625 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39062 | Film No.: 26749689

Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Issuer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)